Literature DB >> 17306958

Cytotoxic and cytokine-inducing properties of Candida glabrata in single and mixed oral infection models.

Lulu Li1, Helena Kashleva, Anna Dongari-Bagtzoglou.   

Abstract

Oral candidiasis is a common opportunistic infection, with Candida albicans being the most prevalent etiologic agent and Candida glabrata emerging as an important pathogen. C. glabrata is frequently co-isolated with C. albicans from oral lesions. Although C. albicans has been shown to trigger significant cytokine responses and cell damage, C. glabrata has not been systematically studied yet. The purpose of this study was to characterize the ability of C. glabrata to induce proinflammatory cytokine responses and host damage as a single infecting organism and in combination with C. albicans, using in vitro models of the oral mucosa. In monolayer oral epithelial cell cultures, C. glabrata failed to induce a significant interleukin-1alpha and interleukin-8 cytokine response and showed lower cytotoxicity, compared to C. albicans. However, C. glabrata triggered a significantly higher granulocyte macrophage colony stimulating factor response than C. albicans. C. glabrata strains showed a strain-dependent tissue damaging ability and a superficial invasion of the mucosal compartment in a three-dimensional (3-D) in vitro model of the human oral mucosa and submucosa. In the 3-D system, co-infection failed to promote host damage beyond the levels of infection with C. albicans alone. These studies indicate that C. glabrata induces cytokines in human oral epithelium in a strain-specific manner, but its tissue/cell damaging ability, compared to C. albicans, is low. Synergy between C. glabrata and C. albicans in cytokine induction and host damage was not observed with the strains tested.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17306958      PMCID: PMC1973167          DOI: 10.1016/j.micpath.2006.12.003

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  39 in total

1.  Candida albicans stimulates cytokine production and leukocyte adhesion molecule expression by endothelial cells.

Authors:  S G Filler; A S Pfunder; B J Spellberg; J P Spellberg; J E Edwards
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 2.  The host cytokine responses and protective immunity in oropharyngeal candidiasis.

Authors:  A Dongari-Bagtzoglou; P L Fidel
Journal:  J Dent Res       Date:  2005-11       Impact factor: 6.116

3.  Development of a novel three-dimensional in vitro model of oral Candida infection.

Authors:  A Dongari-Bagtzoglou; H Kashleva
Journal:  Microb Pathog       Date:  2006-04-19       Impact factor: 3.738

4.  Candida albicans-infected oral epithelial cells augment the anti-fungal activity of human neutrophils in vitro.

Authors:  A Dongari-Bagtzoglou; C Cunha Villar; H Kashleva
Journal:  Med Mycol       Date:  2005-09       Impact factor: 4.076

5.  Bioactive interleukin-1alpha is cytolytically released from Candida albicans-infected oral epithelial cells.

Authors:  A Dongari-Bagtzoglou; H Kashleva; C Cunha Villar
Journal:  Med Mycol       Date:  2004-12       Impact factor: 4.076

6.  Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer.

Authors:  S W Redding; R C Zellars; W R Kirkpatrick; R K McAtee; M A Caceres; A W Fothergill; J L Lopez-Ribot; C W Bailey; M G Rinaldi; T F Patterson
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

7.  Candida albicans triggers interleukin-8 secretion by oral epithelial cells.

Authors:  A Dongari-Bagtzoglou; H Kashleva
Journal:  Microb Pathog       Date:  2003-04       Impact factor: 3.738

8.  Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains.

Authors:  A Serda Kantarcioglu; A Yücel
Journal:  Mycoses       Date:  2002-06       Impact factor: 4.377

Review 9.  Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans.

Authors:  P L Fidel; J A Vazquez; J D Sobel
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

Review 10.  Options for the management of mucosal candidiasis in patients with AIDS and HIV infection.

Authors:  J A Vazquez
Journal:  Pharmacotherapy       Date:  1999-01       Impact factor: 4.705

View more
  15 in total

1.  Chemotherapy-induced oral mucositis and associated infections in a novel organotypic model.

Authors:  T Sobue; M Bertolini; A Thompson; D E Peterson; P I Diaz; A Dongari-Bagtzoglou
Journal:  Mol Oral Microbiol       Date:  2018-02-20       Impact factor: 3.563

2.  Antibacterial effects of blackberry extract target periodontopathogens.

Authors:  O A González; C Escamilla; R J Danaher; J Dai; J L Ebersole; R J Mumper; C S Miller
Journal:  J Periodontal Res       Date:  2012-07-19       Impact factor: 4.419

3.  Effects of bovine lactoferrin to oral Candida albicans and Candida glabrata isolates recovered from the saliva in elderly people.

Authors:  Akino Komatsu; Tazuko Satoh; Hiroyuki Wakabayashi; Fumiaki Ikeda
Journal:  Odontology       Date:  2015-01       Impact factor: 2.634

4.  Activation of MAPK/c-Fos induced responses in oral epithelial cells is specific to Candida albicans and Candida dubliniensis hyphae.

Authors:  David L Moyes; Celia Murciano; Manohursingh Runglall; Arinder Kohli; Ayesha Islam; Julian R Naglik
Journal:  Med Microbiol Immunol       Date:  2011-06-25       Impact factor: 3.402

5.  Candida glabrata persistence in mice does not depend on host immunosuppression and is unaffected by fungal amino acid auxotrophy.

Authors:  I D Jacobsen; S Brunke; K Seider; T Schwarzmüller; A Firon; C d'Enfért; K Kuchler; B Hube
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

Review 6.  Immune defence mechanisms and immunoenhancement strategies in oropharyngeal candidiasis.

Authors:  Cristina Cunha Villar; Anna Dongari-Bagtzoglou
Journal:  Expert Rev Mol Med       Date:  2008-10-13       Impact factor: 5.600

7.  Epithelial GM-CSF induction by Candida glabrata.

Authors:  L Li; A Dongari-Bagtzoglou
Journal:  J Dent Res       Date:  2009-08       Impact factor: 6.116

8.  Anticandidal activity and biocompatibility of a rechargeable antifungal denture material.

Authors:  C C Villar; A L Lin; Z Cao; X-R Zhao; L-A Wu; S Chen; Y Sun; C-K Yeh
Journal:  Oral Dis       Date:  2012-09-07       Impact factor: 3.511

Review 9.  Two unlike cousins: Candida albicans and C. glabrata infection strategies.

Authors:  Sascha Brunke; Bernhard Hube
Journal:  Cell Microbiol       Date:  2013-01-14       Impact factor: 3.715

10.  Candida glabrata Binding to Candida albicans Hyphae Enables Its Development in Oropharyngeal Candidiasis.

Authors:  Swetha Tati; Peter Davidow; Andrew McCall; Elizabeth Hwang-Wong; Isolde G Rojas; Brendan Cormack; Mira Edgerton
Journal:  PLoS Pathog       Date:  2016-03-30       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.